Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials.

@article{Hsia2008UseOR,
  title={Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials.},
  author={Cyrus Hsia and Ian H. Chin-Yee and Vivian Charles McAlister},
  journal={Annals of surgery},
  year={2008},
  volume={248 1},
  pages={61-8}
}
CONTEXT Benefits of recombinant activated factor VII (rFVIIa) in hemorrhage may be lost because of thromboembolic events (TAE). METHOD MEDLINE, EMBASE, BIOSIS, CINAHL, Science Citation Index Expanded, clinicaltrials.gov were searched for placebo controlled trials of rFVIIa in patients without hemophilia. Reports of 22 randomized controlled trials were… CONTINUE READING